Skip to main content
. Author manuscript; available in PMC: 2018 Sep 1.
Published in final edited form as: J Neuroendocrinol. 2017 Sep;29(9):10.1111/jne.12514. doi: 10.1111/jne.12514

Table 4.

Real-time RTPCR results from Experiment 3

Homecage Restraint Duration Extension Acute Restraint + Swim Restraint History + Swim Restraint History Only Statistical analyses
PVN
 β-actin 109.9 ± 14.6 106.8 ± 15.6 108.4 ± 12.0 111.3 ± 7.9 118.6 ± 8.25 F(4,35) = 0.14, p > 0.05
 TNF-α 103.5 ± 10.0 95.9 ± 9.7 76.0 ± 5.4 71.5 ± 8.6 87.6 ± 7.6 F(4,33) = 2.39, p > 0.05
 IL-1β 110.2 ± 18.7ab 165.7 ± 49.8ab 325.6 ± 67.8c 194.4 ± 37.7b 71.7 ± 7.0a F(4,34) = 5.40, p < 0.01
 IL-6 101.6 ± 6.2 134.1 ± 27.0 127.3 ± 19.2 146.0 ± 24.1 100.7 ± 12.0 F(4,34) = 1.16, p > 0.05
 c-Fos 108.27 ± 18.1a 224.2 ± 154.9d 718.0 ± 26.5b 555.0 ± 35.1c 116.3 ± 6.7a F(4,35) = 155.0, p < 0.001
 CD14 107.4 ± 16.6 114.3 ± 22.3 107.4 ± 16.6 105.6 ± 10.4 89.4 ± 5.4 F(4,35) = 0.36, p > 0.05
 CD200 103.3 ± 8.7 103.4 ± 12.2 117.7 ± 7.7 118.0 ± 6.2 110.9 ± 5.6 F(4,35) = 0.74, p > 0.05
 CD200R 110.4 ± 16.6 95.4 ± 12.8 76.7 ± 11.7 87.4 ± 8.1 116.4 ± 10.1 F(4,35) = 1.77, p > 0.05
HPC
 β-actin 104.9 ± 10.5 111.9 ± 5.7 105.2 ± 7.6 109.2 ± 7.6 106.3 ± 7.8 F(4,35) = 0.14, p > 0.05
 TNF-α 103.1 ± 9.3 82.2 ± 6.8 97.9 ± 6.8 91.5 ± 11.2 92.5 ± 36.2 F(4,35) = 0.65, p > 0.05
 IL-1β 102.1 ± 8.2abc 97.6 ± 4.4ac 117.7 ± 16.4ab 131.3 ± 12.5b 86.7 ± 5.0c F(4,35) = 2.88, p < 0.05
 IL-6 108.7 ± 17.6a 148.4 ± 17.2ab 195.8 ± 18.3b 184.1 ± 23.9b 125.1 ± 12.8a F(4,35) = 4.14, p < 0.01
 c-Fos 106.0 ± 14.4a 111.4 ± 19.8a 560.2 ± 42.3b 458.6 ± 82.1b 109.0 ± 8.69a F(4,35) = 26.86, p < 0.001
 CD14 105.8 ± 14.7 116.9 ± 11.9 124.9 ± 10.5 128.8 ± 12.2 126.7 ± 13.4 F(4,35) = 0.56, p > 0.05
 CD200 101.4 ± 6.6 132.2 ± 8.3 109.4 ± 5.9 115.7 ± 8.4 115.0 ± 6.6 F(4,35) = 2.45, p > 0.05
 CD200R 105.9 ± 15.5 107.4 ± 17.7 89.9 ± 9.1 79.2 ± 6.3 104.7 ± 11.2 F(4,35) = 1.01, p > 0.05
PFC
 β-actin 101.7 ± 7.3 89.2 ± 6.3 80.0 ± 12.9 91.2 ± 11.5 93.9 ± 8.8 F(4,34) = 0.66, p > 0.05
 TNF-α 109.9 ± 18.3a 56.7 ± 7.9b 65.0 ± 7.7b 55.2 ± 6.9b 77.4 ± 13.3ab F(4,34) = 3.85, p < 0.05
 IL-1β 110.2 ± 19.3a 138.7 ± 9.0ac 182.7 ± 11.2bc 212.4 ± 22.1b 131.1 ± 19.2a F(4,35) = 6.02, p < 0.001
 IL-6 113.9 ± 19.0 117.6 ± 17.1 139.1 ± 14.1 130.4 ± 25.8 112.8 ± 21.2 F(4,34) = 0.31, p > 0.05
 c-Fos 109.1 ± 17.7a 206.6 ± 18.8a 1082.4 ± 67.2b 814.8 ± 78.6c 141.4 ± 9.9a F(4,35) = 87.49, p < 0.001
 CD14 109.3 ± 16.5 85.6 ± 8.9 93.1 ± 9.2 86.9 ± 12.1 85.2 ± 8.2 F(4,35) = 0.80, p > 0.05
 CD200 102.9 ± 8.8 87.8 ± 8.9 82.9 ± 12.2 82.8 ± 11.4 91.0 ± 8.7 F(4,35) = 0.67, p > 0.05
 CD200R 105.4 ± 11.7 108.7 ± 19.6 117.8 ± 12.8 78.9 ± 10.9 118.0 ± 15.0 F(4,35) = 1.25, p > 0.05

Note. Means and SEM for Experiment 3. Gene expression data in the paraventricular nucleus of the hypothalamus (PVN), prefrontal cortex (PFC), and hippocampus (HPC) were adjusted to β-actin as a housekeeper and expressed as percent change from the control group (homecage). Bold text indicates a significant effect; data points marked with differing letters are significantly different from one another (p < 0.05).